Ann: Lumos Receives US FDA Clearance for FebriDx, page-404

No, the share price will recover once the people who have bought in at high levels and are down stop selling. It's a technical/charting issue.

And yes. Very rare to get this kind of run without directors doing a CR. It probably highly likely a CR will be done to fund sales program and capital costs for new devices unless they have access to capital already. No traders want to be caught overnight holding after the first day or two when this kind of run happens.

For investors, they should have no worries if they believe in the utility of the device.